Arrangement - Side 5
Vil du bli med på søknadsprosessen i 2020/2021 for finansiering av nye tverrfaglige forskningsgrupper innen livsvitenskap? Da bør du delta på et av UiO:Livsvitenskaps informasjonsmøter.
Vil du bli med på søknadsprosessen i 2020/2021 for finansiering av nye tverrfaglige forskningsgrupper innen livsvitenskap? Da bør du delta på et av UiO:Livsvitenskaps informasjonsmøter.
“The good, the bad and the ugly”. Why would we need a Centre for Healthy Ageing at the University of Oslo (UiO) and why should it be an inter-disciplinary approach? The 4th NO-Age meeting has compiled a high caliber inter-disciplinary speakers to share and discuss their expertise on such topics.
SPARK Norway Educational Forum are meetings organized by UiO:Life Science and SPARK Norway partners.
UiO-ansatte med tilknytning til livsvitenskap inviteres til digitalt informasjonsmøte om utviklingen for Livsvitenskapsbygget.
Dr. Esti Yeger-Lotem, Associate Professor, Department of Clinical Biochemistry & Pharmacology, Ben-Gurion University of the Negev, Israel, will present her lecture "Elucidating disease mechanisms via their tissue-selectivity."
Dr. Juho Rousu, Professor in Computer Science, Aalto University, Finland, will present the lecture "Machine Learning of Drug Combination Responses."
Dr. Shaun Mahony, Assistant Professor, Biochemistry & Molecular Biology Department, Penn State University, USA, will present the lecture "Using neural networks to characterize the predeterminants of induced transcription factor binding sites."
Det dukker ofte opp en lege i Ibsens verker. Ibsens leger har ofte høy status og skaper spenning i handlingen. Legen kan være en kjær og tillitsvekkende venn og en som fortrolig lytter til familiens mange hemmeligheter – eller den som kommer med en brannfakkel og skaper røre.
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Dr. Ville Mustonen, Professor at the Department of Computer Science and Institute of Biotechnology, University of Helsinki and the Helsinki Institute for Information Technology, Finland, will present the lecture "Using computational methods and evolutionary theory to combat drug resistance."
Dr. Evangelia Petsalaki, Group Leader at EMBL-EBI, will present the lecture entitled "Integrative studies of context-specific signalling."
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Dr. Florian Markowetz, Group Leader of the Integrative Cancer Biology team at the Cancer Research UK Cambridge Institute, Cambridge, UK, will present his current research.
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Having a new idea is not enough to create a new innovation. The hardest part is to build a successful business around it – this is the entrepreneurial challenge. One of the key elements that needs to be worked out is the right Go-To-Market strategy.
Dr. Matti Nykter, Professor at the Tampere University, Finland, will present the lecture "Computational analysis to understand aberrant gene expression and treatment induced responses in prostate cancer."
To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.
Dr. Colm Ryan, Assistant Professor at the University College Dublin, will present the lecture "Identifying robust genetic interactions in cancer."
Forming a business partnership can be beneficial or even vital to obtain success, but it has to be done correctly. If not, it can be catastrophic. Learn more about what it takes to secure a successful partnering and finance setup. What are the pitfalls? What is critical? What are the dos and don'ts?
Procedures that work in the lab don’t always scale-up seamlessly into production in the life science industry. Process development while staying compliant will be required. What should be considered when you work in lab-scale to make the transition to production smoother? What are the common pitfalls, and what are the dos and don’ts?
Dr. Tero Aittokallio, Professor at the Oslo Centre for Biostatistics and Epidemiology and Group Leader at the Institute for Cancer Research, Oslo, Norway, will present his lecture "Predictive modelling of drug combination effects for precision medicine."
Vi feirer 50-årsdagen for Odd Hassels Nobelpris i kjemi: Program og påmelding til Hassel-seminaret 31. oktober til og med 1. november.
This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.
Repurposing of drugs can potentially bring medications with known safety profiles to new patient groups. What is the industry looking for when they consider to invest in a repurposing project? What is the regulatory framework in this area? How is IP handled?